Literature DB >> 9790984

Three novel integrin beta3 subunit missense mutations (H280P, C560F, and G579S) in thrombasthenia, including one (H280P) prevalent in Japanese patients.

H Ambo1, T Kamata, M Handa, M Taki, M Kuwajima, Y Kawai, A Oda, M Murata, Y Takada, K Watanabe, Y Ikeda.   

Abstract

We analyzed three unrelated Japanese patients with type II Glanzmann thrombasthenia (GT) for associated mutations. Polymerase chain reaction and subsequent direct sequencing of platelet RNA and genomic DNA revealed three single nucleotide substitutions of the integrin beta3 subunit gene (His (CAT)-280 to Pro (CCT), Cys (TGT)-560 to Phe (TTT), and Gly(GGC)-579 to Ser(AGC)). Interestingly, the three unrelated patients all had the H280P mutation; one was homozygous and the other two heterozygous for this mutation. Ectopic expression of wild type and mutant complexes in Chinese hamster ovary cells revealed decreased surface expression of the mutated alphaIIbbeta3 complexes, thus demonstrating that these mutations may result in the mild GT phenotypes. The identification of three unrelated patients having the same mutation (H280P) suggests that this mutation might be prevalent in the Japanese thrombasthenic population. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9790984     DOI: 10.1006/bbrc.1998.9526

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Demystified...adhesion molecule deficiencies.

Authors:  D Inwald; E G Davies; N Klein
Journal:  Mol Pathol       Date:  2001-02

2.  Critical cysteine residues for regulation of integrin alphaIIbbeta3 are clustered in the epidermal growth factor domains of the beta3 subunit.

Authors:  Tetsuji Kamata; Hironobu Ambo; Wilma Puzon-McLaughlin; Kenneth Khiem Tieu; Makoto Handa; Yasuo Ikeda; Yoshikazu Takada
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

3.  C560Rβ3 caused platelet integrin αII b β3 to bind fibrinogen continuously, but resulted in a severe bleeding syndrome and increased murine mortality.

Authors:  J Fang; P Nurden; P North; A T Nurden; L M Du; N Valentin; D A Wilcox
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

4.  Novel Mutations in the GPIIb and GPIIIa Genes in Glanzmann Thrombasthenia.

Authors:  Daniele Pillitteri; Ann-Kathrin Pilgrimm; Carl Maximilian Kirchmaier
Journal:  Transfus Med Hemother       Date:  2010-09-15       Impact factor: 3.747

Review 5.  Advances in alloimmune thrombocytopenia: perspectives on current concepts of human platelet antigens, antibody detection strategies, and genotyping.

Authors:  Tomoya Hayashi; Fumiya Hirayama
Journal:  Blood Transfus       Date:  2015-04-30       Impact factor: 3.443

Review 6.  Glanzmann thrombasthenia: state of the art and future directions.

Authors:  Alan T Nurden; Xavier Pillois; David A Wilcox
Journal:  Semin Thromb Hemost       Date:  2013-08-08       Impact factor: 4.180

Review 7.  Profiling the Genetic and Molecular Characteristics of Glanzmann Thrombasthenia: Can It Guide Current and Future Therapies?

Authors:  Alan Nurden
Journal:  J Blood Med       Date:  2021-07-08

8.  Molecular dynamics analysis of a novel β3 Pro189Ser mutation in a patient with glanzmann thrombasthenia differentially affecting αIIbβ3 and αvβ3 expression.

Authors:  Michel Laguerre; Essa Sabi; Martina Daly; Jacqueline Stockley; Paquita Nurden; Xavier Pillois; Alan T Nurden
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

9.  Morphometric analysis of spread platelets identifies integrin αIIbβ3-specific contractile phenotype.

Authors:  Sebastian Lickert; Simona Sorrentino; Jan-Dirk Studt; Ohad Medalia; Viola Vogel; Ingmar Schoen
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

10.  Genetic Confirmation and Identification of Novel Variants for Glanzmann Thrombasthenia and Other Inherited Platelet Function Disorders: A Study by the Korean Pediatric Hematology Oncology Group (KPHOG).

Authors:  Eu Jeen Yang; Ye Jee Shim; Heung Sik Kim; Young Tak Lim; Ho Joon Im; Kyung-Nam Koh; Hyery Kim; Jin Kyung Suh; Eun Sil Park; Na Hee Lee; Young Bae Choi; Jeong Ok Hah; Jae Min Lee; Jung Woo Han; Jae Hee Lee; Young-Ho Lee; Hye Lim Jung; Jung-Sook Ha; Chang-Seok Ki
Journal:  Genes (Basel)       Date:  2021-05-06       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.